Antoni Camins
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 134 publications
Cognitive-enhancing drugs in Phase II clinical trials for Alzheimer's disease: emerging therapeutic candidates.
Journal: Expert opinion on investigational drugs
Published: July 30, 2026
Cognitive-enhancing drugs in Phase II clinical trials for Alzheimer's disease: emerging therapeutic candidates.
Journal: Expert opinion on investigational drugs
Published: July 30, 2026
Nut consumption as a therapeutic strategy to preserve brain function, attenuate neuropathology, and modulate cross-tissue microRNAs in a mouse model of Alzheimer's disease.
Journal: Food & function
Published: July 08, 2026
Epigallocatechin-3-gallate attenuates colistin-induced neuro and nephrotoxicity by preserving mitochondrial function and reducing oxidative stress.
Journal: Biochemical pharmacology
Published: February 24, 2026
From comorbidity to continuum: Alzheimer's disease and epilepsy are connected-now what?
Journal: Neuroscience and biobehavioral reviews
Published: January 31, 2026
Therapeutic potential of phytocannabinoids in depression and cognitive dysfunction: Evidence from preclinical models.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 17, 2026
Natural senotherapeutics in respiratory health: Addressing cellular senescence, inflammaging, and immunosenescence in the aging lung.
Journal: European journal of pharmacology
Published: October 27, 2025
Targeting the liver-brain axis: Licochalcone A as a therapeutic agent against HFD-induced neurodegeneration.
Journal: Biochemical pharmacology
Published: October 24, 2025
Licochalcone a enhances cognitive resilience in APP/PS1 Mice by modulating glucose metabolism, Aβ burden, and neuroinflammation.
Journal: GeroScience
Published: September 08, 2025
B-rich colistin and B-pure colistin as novel strategies to increase the therapeutic window of polymyxin antibiotic therapy.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 15, 2025
Colistin-loaded biodegradable nanoparticles as a promising antibacterial medication to reduce colistin-induced toxicity.
Journal: International journal of pharmaceutics
Published: April 27, 2025
Protective effects of irbesartan against neurodegeneration in APP/PS1 mice: Unraveling its triple anti-apoptotic, anti-inflammatory and anti-oxidant action.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 19, 2025
Last Updated: 09/26/2026